Sign in
4

Changes in Ownership

ORTHOPEDIATRICS CORP Filed Acc 0001425450-21-000038

CEO sold 5,097 shares at $55.88 ($284,820)

  • CEO acquired 5,277 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Throdahl Mark C · CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-03-01 Sale : show line 1 in the form −5,097 $55.88 $284,820 146,460 D
2021-03-02 Grant or award : show line 2 in the form +5,277 151,737 D
Open-market sales · 5,097 sh · avg $55.88 · $284,820
Loading xslF345X03/wf-form4_161478737249168.xml…